Effects of inhaled combined Benzene, Toluene, Ethylbenzene, and Xylenes (BTEX): Toward an environmental exposure model
CJ Davidson, JH Hannigan, SE Bowen - Environmental toxicology and …, 2021 - Elsevier
Combined environmental exposures to the volatile organic compounds (VOCs) Benzene,
Toluene, Ethylbenzene, and Xylene (BTEX) pose clear risks to public health. Research into …
Toluene, Ethylbenzene, and Xylene (BTEX) pose clear risks to public health. Research into …
Gut-derived protein-bound uremic toxins
AL Graboski, MR Redinbo - Toxins, 2020 - mdpi.com
Chronic kidney disease (CKD) afflicts more than 500 million people worldwide and is one of
the fastest growing global causes of mortality. When glomerular filtration rate begins to fall …
the fastest growing global causes of mortality. When glomerular filtration rate begins to fall …
A brief history of carbon monoxide and its therapeutic origins
CP Hopper, PN Zambrana, U Goebel, J Wollborn - Nitric Oxide, 2021 - Elsevier
It is estimated that 10% of carbon throughout the cosmos is in the form of carbon monoxide
(CO). Earth's earliest prebiotic atmosphere included the trinity of gasotransmitters CO, nitric …
(CO). Earth's earliest prebiotic atmosphere included the trinity of gasotransmitters CO, nitric …
Taurine – a possible fingerprint biomarker in non-muscle invasive bladder cancer: A pilot study by 1H NMR spectroscopy
Urinary bladder cancer is a major epidemiological problem that continues to grow each
year. It opens avenues for investigative research for the identification of new disease …
year. It opens avenues for investigative research for the identification of new disease …
Metabonomic profiling of bladder cancer
Early diagnosis and life-long surveillance are clinically important to improve the long-term
survival of bladder cancer patients. Currently, a noninvasive biomarker that is as sensitive …
survival of bladder cancer patients. Currently, a noninvasive biomarker that is as sensitive …
[PDF][PDF] Evaluation of toluene exposure in workers at industrial area of Sidoarjo, Indonesia by measurement of urinary hippuric acid
M Sahri, N Widajati - 2013 - sid.ir
Background: Toluene is a harmful substance still being used as a solvent and catalyst in
many industries that can increase the level of urinary hippuric acid (UHA). This study was …
many industries that can increase the level of urinary hippuric acid (UHA). This study was …
Determination of dimethyl sulfoxide and dimethyl sulfone in urine by gas chromatography–mass spectrometry after preparation using 2, 2‐dimethoxypropane
A Takeuchi, S Yamamoto, R Narai… - Biomedical …, 2010 - Wiley Online Library
A method for routinely determination of dimethyl sulfoxide (DMSO) and dimethyl sulfone
(DMSO2) in human urine was developed using gas chromatography–mass spectrometry …
(DMSO2) in human urine was developed using gas chromatography–mass spectrometry …
Efficacy of urinary hippuric acid as a biomarker of low level exposure to toluene in petroleum depot workers
Z NAGHAVI-KONJIN, M REZAZADEH-AZARI… - International Journal of …, 2013 - ijoh.tums.ac.ir
Exposure to toluene can be associate with genotoxicity, neurological dysfunction,
reproductive toxicity, and etc. Biomonitoring of hippuric acid (HA) is used for a long time as …
reproductive toxicity, and etc. Biomonitoring of hippuric acid (HA) is used for a long time as …
[PDF][PDF] Development of a hippuric acid-hydrolysing enzyme for monitoring toluene exposure
Y Nishiya, K Nagoshi, S Shinki, S Imai… - Int J Anal Bio-Sci Vol, 2021 - e-jabs.umin.jp
Toluene is used in large quantities as an organic solvent in paint industries. Following
toluene exposure, it is metabolized in the body of workers to yield hippuric acid in urine. An …
toluene exposure, it is metabolized in the body of workers to yield hippuric acid in urine. An …
Toluene toxicity: a case report of transdermal exposure causing hypokalemic paralysis
KMH Tran, K Hinther, J Bueti… - … Journal of Kidney …, 2019 - journals.sagepub.com
Rationale: Hypokalemia is a common finding. Typically asymptomatic presentations of
neuromuscular weakness emerge at levels below 2.5 mmol/L. Causes include …
neuromuscular weakness emerge at levels below 2.5 mmol/L. Causes include …